Late Effects in Hematopoietic Cell Transplant Recipients with Acquired Severe Aplastic Anemia: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Dec 01, 2012
- Source ID
- 10.1016/j.bbmt.2012.06.018
Entities
People
- Adriana Seber
- Amir Steinberg
- Bipin N Savani
- Brandon M. Hayes-lattin
- Carmen M. Sales-bonfim
- Christine Duncan
- David A. Jacobsohn
- David Buchbinder
- Diane J. Nugent
- Donna A. Wall
- Gregory A. Hale
- Hillard M Lazarus
- Jacek H. Winiarski
- Jack W. Hsu
- Jakob R. Passweg
- Joerg Halter
- Joseph Pidala
- Kasiani C. Myers
- Kimberly A. Kasow
- Lamis K. Eldjerou
- Lolie C. Yu
- Mahmoud Aljurf
- Mitchell S Cairo
- Mohamed L Sorror
- Navneet S Majhail
- Paulette Mehta
- Rammurti T. Kamble
- Robert Chow
- Ruta Brazauskas
- Susan K. Parsons
- Vijay Reddy
- Vikas Gupta
- William A. Wood
- Zhiwei Wang
Organizations
- ARIAD Pharmaceuticals
- Amgen
- Blue Cross Blue Shield Association
- Celgene
- CellGenix (Germany)
- Children’s Leukemia Research Association
- Elevance Health, Inc.
- GSK
- HistoGenetics (United States)
- Kiadis Pharma (Netherlands)
- Leukemia & Lymphoma Society
- Medical College of Wisconsin
- Merck & Co.
- Miltenyi Biotec
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Marrow Donor Program
- Office of Naval Research
- Roche (United States)
- Sanofi-Aventis
- Seagen
- Sigma-Tau Pharmaceuticals (United States)
- StemCyte
- Swedish Orphan Biovitrum
- Takeda Oncology
- Tarix Orphan (United States)
- Terumo BCT (United States)